Defective suppression of the aldosterone biosynthesis during stroke permissive diet in the stroke-prone phenotype of the spontaneously hypertensive rat

Basic Research in Cardiology

Volumn 95, Issue 2, 2000, Pages 84-92

  Enea, Iolanda ^a   De Paolis, Paola ^a   Porcellini, Antonio ^a   Piras, Ornella ^c   Savoia, Carmine ^c   Russo, Rosaria ^a   Giliberti, Rosangela ^a   Gigante, Bruna ^c   Rubattu, Speranza ^a   Conte, Giuseppe ^c   Ganten, Detlev ^b   Volpe, Massimo ^a  

^a IRCCS NEUROMED   (Italy)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c NONE

Author keywords

Adrenal; Aldosterone; Hypertension; Renin angiotensin system; Stroke

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; SODIUM;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ESSENTIAL HYPERTENSION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM EXCRETION; STEROIDOGENESIS; STROKE;

ALDOSTERONE; ANIMALS; ATRIAL NATRIURETIC FACTOR; CEREBROVASCULAR ACCIDENT; HYPERTENSION; JAPAN; MALE; RATS; RATS, INBRED SHR; RENIN; SODIUM CHLORIDE, DIETARY;

EID: 0034013053     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003950050168     Document Type: Article

References (40)

1. Okamoto K, Yamori Y, Nagaoka A (1974) Establishment of the stroke prone spontaneously hypertensive rat (SHR). Circ Res 34/35 (suppl I): 1143-1153
2. Yamori Y, Horie R, Tanase H, Fuyiwara K, Nara Y, Lovenberg W (1984) Possible role of nutritional factors in the incidence of cerebral lesions in stroke prone spontaneously hypertensive rats. Hypertension 6: 49-53
3. Nagaoka A, Iwatsuka H, Suzuoki Z, Okamoto K (1976) Genetic predisposition to stroke in spontaneously hypertensive rats. Am J Physiol 230: 1354-1359
4. Shibota M, Nagaoka A, Shino A, Fujita T (1979) Renin angiotensin system in stroke prone spontaneously hypertensive rats. Am J Physiol 236: H409-H416
5. Mizuno K, Shigatami S, Matsui J, Fukuchi S (1981) Effect of sodium intake on the brain and the aortic angiotensin converting enzyme activity in SHR. Jpn Heart J. 22: 839-845
6. Haddy FJ (1987) Dietary sodium and potassium in the genesis, therapy and prevention of hypertension. J Am Coll Nutr 6: 261-270
7. Kawashima K, Shono K, Sokaba H (1978) Plasma renin activity and excretion of water and electrolytes in stroke prone SHR rats. Jpn Heart J 19: 657-658
8. Nagaoka A, Shino A, Shibota M (1980) Implication of renal perfusion pressure in stroke of SHR. Am J Physiol 238: H317-H324
9. Nagaoka A, Kakihoma M, Suno M, Hamayo K (1981) Renal hemodynamics and sodium excretion in SHRsp. Am J Physiol 241: F244-F249
10. Ikemoto F, Takada T, Itoh S, Miyazaki M, Yamamoto K (1986) Prevention of development of hypertension and stroke in SHRsp by chronic treatment with convert-ing enzyme inhibitor SA 446. J Hypertens 4 (supp 13): S499-S500
11. Stier CT, Benter IF, Ahmad S, Zuo H, Selig N, Roethel S (1989) Enalapril prevents stroke and kidney dysfunction in salt loaded stroke prone SHR. Hypertension 1989 13: 115-121
12. Stier CT, Chander P, Gutstein WH, Levine S, Iskovitz HD (1991) Therapeutic benefit of captopril in salt loaded stroke prone SHR is independent of hypertensive effect. Am J Physiol 4: 680-687
13. Camargo MJF, Lutterotti N, Pecker MS, James GD, Timmermans PBMWM, Laragh JH (1991) DUP 753 increases survival in SHRsp fed a high sodium diet. Am J Hypertension (suppl): 341S-345S
14. Tobian L, Lange J, Ulm K, Wold L, Iwai J (1985) Potassium reduces cerebral hemorrhage and death rate in hypertensive rats even when blood pressure is not lowered: Hypertension 7 (suppl 1): 1110-1114
15. Volpe M, Camargo MJF, Mueller FB, Campbell WG, Sealey JE, Pecker MS et al. (1990) Relation of plasma renin to end organ damage and to protection of K feeding in stroke prone hypertensive rats. Hypertension 15: 318-326
16. Volpe M, Rubattu S, Ganten D, Enea I, Russo R, Lembo G, Mirante A, Condorelli GL, Trimarco B (1993) Dietary salt excess unmasks blunted aldosterone suppression and sodium retention in the stroke prone phenotype of the spontaneously hypertensive rat. J Hypertens 11: 793-798
17. Rocha R, Chander PN, Khanna K, Zuckerman A, Stier CT Jr (1998) Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension 31 (1 Pt 2): 451-458
18. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT (1990) Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 67: 1355-1364
19. Brilla CG, Matsubara LS, Webwr KT (1993) Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 25: 563-575
20. Hall CE and Hall O (1965) Hypertension and Hypersalimenlation. Lab Invest 14; 3: 285-294
21. Preibisz JJ, Sealey JE, Aceto RM, Laragh JH (1982) Plasma renin activity measurements: an update. Cardiovasc Rev Rep 5: 787-804
22. Tremblay A, Parker KL, Lehoux JG (1992) Dietary potassium supplementation and sodium restriction stimulate aldosterone synthase but not 11 β-hydroxylase P-450 messenger ribonucleic acid accumulation in rat adrenals and require angiotensin II production. Endocrinology 130: 3152-3158
23. Beierwaltes WH, Arendshorst WJ, Klemmer PJ (1982) Electrolyte and water balance in young spontaneously hypertensive rats. Hypertension 4: 908-915
24. Iso H, Jacobs DR Jr, Wentworth D, Neaton JD, Cohen JD (1989) Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial (see comments). N Engl J Med 320: 904-910
25. Welin L, Svardsudd K, Wilhelmsen L, Larsson B, Tibblin G (1987) Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med 317: 521-526
26. Diaz JF, Hachinski VC, Pederson LL, Donald A (1986) Aggregation of multiple risk factors for stroke in siblings of patients with brain infarction and transient ischemic attacks. Stroke 17: 1239-1242
27. Brass LM, Isaacson JL, Merikangas KR, Robinette CD (1992) A study of twins and stroke. Stroke 23: 221-223
28. Medline: National Library of Medicine Bethesda, Maryland USA
29. Volpe M, Rubattu R (1994) Pathophysiological aspects of genetically determined hypertension in rats with special emphasis on stroke-prone spontaneously hypertensive rats. In: Ganten D., de Jong W (eds) Handbook of Hypertension. Experimental and Genetic Models of Hypertension. Elsevier Science Publisher
30. Dietz R, Schömig A, Rascher W (1984) Pathophysiological aspects of genetically determined hypertension in rats, with special emphasis on stroke-prone spontaneously hypertensive rats. In: Birkenhäger WH, Reid JL (eds) Experimental and Genetic Models of Hypertension. Elsevier; Amsterdam
31. Volpe M, Gigante B, Enea I, Porcellini A, Russo R, lee Min Ae, Magri P, Condorelli G, Savoia C, Lindpaintner K, Rubattu R (1997) Role of tissue renin in the regulation of aldosterone biosynthesis in the adrenal cortex of nephrectomized rats. Circ Res 81: 857-864
32. Schiffrin EL (1988) Regulation of receptor for atrial natriuretic peptide in the rat and human. Cardiovasc Drug Therapy 2 (4): 493-500
33. Maack T (1996) Role of atrial natriuretic factor in volume control. Kidney Int 49 (6): 1732-1737
34. Rubattu S, Volpe M, Kreutz R, Ganten U, Ganten D, Lindpaintner K (1996) Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model complex human disease. Nat Genet 13: 429-434
35. Volpe M, Tritto C, Condorelli M (1993) Hormonal profile in mild heart failure. Acta Cardiol 48: 483-494
36. Gould AB, Goodman SA (1987) Effect of a renin-system inhibitor on blood vessel adaptation in spontaneoulsy hypertensive rats. J Hypertens 5 (Suppl 2): S53-S58
37. Nagase M, Katafuchi T, Hirase S, Fujita T (1997) Tissue distribution and localization of natriuretic peptide receptor subtypes in stroke-prone spontaneously hypertensive rats. J Hypertens 15: 1235-1243
38. Grandclement B, Ronsin B, Morel G (1997) The three subtypes of Atrial Natriuretic Peptide (ANP) receptors are expressed in the rat adrenal gland. Biol Cell 89(1): 29-41
39. Cozza EN, Gomez-Sanchez CE, Foecking MF, Chiou S (1989) Endothelin binding to cultured calf adrenal zona glomerulosa cells and stimulation of aldosterone secretion. J Clin Invest 84 (3): 1032-1035
40. Rocha R, Cho J, Burstein J, Zuckerman A, Khanna K, Proveen C, Stier CT Jr (1997) Spironolactone, a mineralocorticoid receptor antagonist protects stroke prone SHR against vascular injury. Hypertension 30 (3) (Part 1): 479 (Abstract)